Keywords: gw, grepafloxacin, launched, 2nd, market, usa, glaxo

GW's Grepafloxacin Launched In 2nd Market, The USA

Article | 24 December 1997

Print This

Glaxo Wellcome has launched its new once-daily quinolone antibioticRaxar (grepafloxacin) onto the market in the USA. It was first launched ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in